Literature DB >> 32989421

A rare case of Mycoplasma-induced rash and mucositis in a 44-year-old female patient.

Anne-Sophie Smilga1,2, Suzel Fournier1,2, Hélène Veillette1,2, Marie-Ève Légaré3,2, Martin Gilbert1,2.   

Abstract

Entities:  

Keywords:  EM, erythema multiforme; MIRM, mycoplasma-induced rash and mucositis; PCR, polymerase chain reaction; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; drug reactions; female adult patient; mucocutaneous eruptions; mycoplasma-induced rash and mucositis

Year:  2020        PMID: 32989421      PMCID: PMC7510416          DOI: 10.1016/j.jdcr.2020.09.014

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Introduction

Mycoplasma-induced rash and mucositis (MIRM), also referred to as “reactive infectious mucosal-predominant eruption,” is a relatively newly described entity. Differential diagnosis includes erythema multiforme, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis. It is characterized by clinical symptoms of pneumonia, including fever and cough, and by mucosal lesions that usually affect 2 or more sites. In about half of the reported cases, it is also accompanied by a cutaneous eruption that is often vesiculobullous and sometimes presents with typical and atypical target lesions. It has been mostly reported in children and young adolescents with a mean age of 12 years, and it affected males in two-thirds of the reported cases., Here, we report an unusual case of MIRM occurring in a middle-aged female.

Case report

A 44-year-old Caucasian woman presented to the emergency department complaining of productive cough with fever for the previous month and painful mucosal lesions for the previous week, with no other pertinent past medical history. She had been taking lamotrigine and levothyroxine for 20 years without interruption, with no other recent medications. Physical examination revealed marked bilateral conjunctival injection (Fig 1), with 360-degree ulcerations of the bulbar conjunctiva and palpebral margins. There was no epithelial deficit on the forniceal and palpebral conjunctiva or on the cornea. She had several erosions and ulcers, 1–2 cm in diameter, on the entire oral mucosa (Fig 2) and, to a lesser extent, on the labia minora of the vulva. Hemorrhagic crusts were also seen on the nasal mucosa. A dozen erythematous papules and vesicles, a few millimeters in diameter, were scattered on the limbs (Fig 3), and there was one atypical target lesion on the left arm (Fig 4). Laboratory studies showed a WBC count of 1042 × 109/L (N = 420–1000) with neutrophil count of 7230 × 109/L (N = 1900–7000) and C-reactive protein level of 254 mg/L (N < 10 mg/L). Renal function and liver enzyme levels remained normal. Herpes simplex polymerase chain reaction (PCR) was negative for both the lesions of the lips and the conjunctiva. Serum IgM for M pneumoniae was positive, and nasopharyngeal swab for M pneumoniae PCR was also positive. PCR for Chlamydophila pneumoniae, Bordetella pertussis, and common viruses, including severe acute respiratory syndrome coronavirus 2, were all negative. Chest X-ray revealed a pulmonary infiltrate in the lower portion of the right lung lobe. Skin biopsy revealed interface dermatitis with numerous basal necrotic keratinocytes.
Fig 1

Marked bilateral conjunctival injection with 360-degree ulcerations of the bulbar conjunctiva and palpebral margins.

Fig 2

Erosions and ulcers on the oral mucosa.

Fig 3

Scattered erythematous papules and vesicles on the limbs.

Fig 4

One atypical target lesion on the left arm.

Marked bilateral conjunctival injection with 360-degree ulcerations of the bulbar conjunctiva and palpebral margins. Erosions and ulcers on the oral mucosa. Scattered erythematous papules and vesicles on the limbs. One atypical target lesion on the left arm. Based on these findings, MIRM was diagnosed. In addition to dermatologists, a multidisciplinary team was involved in the treatment, including infectious disease experts, ophthalmologists, gynecologists, otolaryngologists, and nutritionists. The patient was admitted and successfully treated with clarithromycin, 500 mg orally twice daily for 14 days, and oral prednisone that was started at 50 mg daily (1 mg/kg/day) and then tapered over 10 days. Local treatments included mouthwash with lidocaine, dexamethasone elixir, and prednisolone 1% eye drops. Amniotic membrane grafts were also placed over the entire conjunctival mucosa of both eyes in the form of biological bandages with local anti-inflammatory and antiscarring effects. The patient was hospitalized for a total of 13 days until complete healing of all mucous membranes and skin lesions was achieved.

Discussion

M pneumoniae infection that was ascertained using PCR and an extensive involvement of the ocular, nasal, oral, and genital mucosae was confirmed as classic MIRM due to the sparse and mainly distally distributed cutaneous vesiculobullous lesions. MIRM sine rash and severe MIRM, which are the two other types of MIRM, present with no significant cutaneous rash and widespread non-mucosal blisters or flat, atypical target lesions. Although only recently described, MIRM is now a well-recognized distinct entity. It is almost exclusively seen in the pediatric population, probably because M pneumoniae infections tend to be more symptomatic in this age group. Only four case reports of MIRM in adults were found in the literature, including three men (26-, 27-, and 42-years-old) with classic MIRM and one 46-year-old man with MIRM skin rash.,,, There is a known male predominance in MIRM, with 66% of the identified cases occurring in males, and this predominance may even be more pronounced in the adult population. There is some evidence that men develop more severe lung disease in response to M pneumoniae infections as compared to women. The question is whether this also applies to the skin. To our knowledge, our patient represents the first case of an adult female diagnosed with classic or any other type of MIRM. Regardless of the age and sex of the patient, MIRM is an important diagnosis to consider when a patient presents with an acute mucocutaneous eruption. Indeed, the main differential considerations for MIRM are erythema multiforme, SJS, and toxic epidermal necrosis, and early diagnosis is important for its appropriate management. Caution must be exercised when interpreting the histopathology report because there is nothing pathognomonic for MIRM and it can encompass well-described features of EM and SJS/TEN. MIRM patients generally have a good prognosis overall and respond well to oral antibiotics (e.g., azithromycin or clarithromycin) and immunosuppressive therapy, such as systemic corticosteroids., However, the prevention of severe long-term ocular sequelae, such as those seen in SJS, warrant early and aggressive ophthalmological intervention. In the current case, the medical team kept a low threshold of suspicion for MIRM, despite the patient being an adult woman, which allowed early diagnosis and rapid implementation of the appropriate treatment.
  7 in total

1.  Mycoplasma-Induced Rash and Mucositis in a Father and Son: A Case Report.

Authors:  Hannah Song; Jennifer T Huang; Jennifer K Tan
Journal:  Pediatr Infect Dis J       Date:  2018-07       Impact factor: 2.129

2.  Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice.

Authors:  A L Yancey; H L Watson; S C Cartner; J W Simecka
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Mycoplasma pneumonia: Clinical features and management.

Authors:  Surender Kashyap; Malay Sarkar
Journal:  Lung India       Date:  2010-04

4.  Mycoplasma pneumoniae-associated mucositis with minimal skin manifestations.

Authors:  João Figueira-Coelho; Sofia Lourenço; Ana Cristina Pires; Paula Mendonça; José António Malhado
Journal:  Am J Clin Dermatol       Date:  2008       Impact factor: 7.403

5.  Mycoplasma pneumonia-associated mucositis.

Authors:  Cyril Varghese; Korosh Sharain; Joseph Skalski; Kannan Ramar
Journal:  BMJ Case Rep       Date:  2014-03-13

Review 6.  Mycoplasma pneumoniae-associated mucositis--case report and systematic review of literature.

Authors:  I Vujic; A Shroff; M Grzelka; C Posch; B Monshi; M Sanlorenzo; S Ortiz-Urda; K Rappersberger
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-02-17       Impact factor: 6.166

7.  Mycoplasma pneumoniae-associated Mucositis: A Recently Described Entity.

Authors:  Inês Zão; Fani Ribeiro; Valter Rocha; Pedro Neto; Carla Matias; Gorete Jesus
Journal:  Eur J Case Rep Intern Med       Date:  2018-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.